PC_050 Methylation biomarkers in non-regressive cervical intraepithelial neoplasia grade 2 lesions: an epigenome wide association study

L. Ellis (1), S. Bowden (1), M. Paraskevaidi (1), D. Lyons (2), E. Paraskevaidis (3), B. Moscicki (4), J. Flanagan (1), M. Kyrgiou (1)
(1) Imperial College London, London, Royaume-Uni, (2) Imperial College Healthcare Nhs Trust, London, Royaume-Uni, (3) University Of Ioannina, Ioannina, Grèce, (4) University Of California In Los Angeles, Los Angeles, États-Unis

PC_054 A cross-sectional study on the seroprevalence of 14 HPV neutralizing antibodies among women with current HPV infection who are negative, positive, or at different stages of cervical lesions

T. Li (1), Y. Liu (2), T. Mutailipu (1), M. Li (1), Y. Chang (3), T. Peng (1), Z. Zhang (1), L. Xie (2), W. Chen (1)
(1) National Cancer Center/cancer Hospital, Chinese Academy Of Medical Sciences And Peking Union Medical College, Beijing, Chine, (2) Sinocelltech Ltd., Beijing, Chine, (3) Sichuan Clinical Research Center For Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital Of University Of Electronic Science And Technology Of China, Chengdu, Chine

PC_061 Long-term Efficacy and Safety of Hexaminolevulinate Photodynamic Therapy (HAL-PDT) in CIN2 Patients: Results from a Phase III Randomized Controlled Trial

L. Zhu (1), P. Hillemanns (2), F. Chen (1), H. Ruan (3), Z. Novak (4), L. Woelber (5), L. Sui (6), B. Li (7), J. Lang (1)
(1) Peking Union Medical College Hospital, Beijing, Chine, (2) Medizinische Hochschule Hannover, Hannover, Allemagne, (3) Nanjing Maternity And Child Health Hospital, Nanjing, Chine, (4) Aranyklinika Gynaecology, Budapest, Hongrie, (5) University Medical Centre Hamburg-Eppendorf, Hamburg, Allemagne, (6) Obstetrics & Gynecology Hospital Of Fudan University, Shanghai, Chine, (7) Asieris Pharmaceuticals, Shanghai, Chine